
zzso of zzso growth factor zzso zzso and zzso factors is associated with the progression of zzso prostate cancer zzso We examined the effects of zzso an inhibitor of vascular zzso growth factor zzso zzso and rearranged during zzso zzso zzso activities, alone or combined with zzso on zzso zzso zzso or zzso zzso zzso cell growth in zzso and in zzso 

Mice bearing zzso or zzso tumors were treated for 3 weeks with zzso zzso or 50 zzso zzso 5 zzso zzso (10 or 30 zzso zzso 1 zzso or their combination zzso or high zzso zzso tumors were analyzed for expression of zzso zzso zzso and production of zzso 

On zzso zzso at both doses zzso tumor growth, whereas zzso at both doses exerted strong zzso zzso The zzso zzso combination resulted in tumor growth similar to that of control, whereas the high-dose combination induced a significant zzso zzso In contrast, on zzso the zzso of zzso had no effect on tumor growth, whereas the high-dose of zzso significantly inhibited tumor zzso zzso at both doses exerted moderate and transient zzso zzso The combination of high-dose zzso with high-dose zzso resulted in zzso effects, which were lower than expected from the sum of individual drug zzso zzso tumor analyses revealed zzso of the zzso pathways in zzso relative to zzso 

Present results suggest that zzso should not be associated with zzso in zzso or zzso prostate cancer zzso The use of high-dose zzso alone may warrant further investigation in patients with zzso zzso zzso zzso zzso 

